Colette DeJong
Overview
Explore the profile of Colette DeJong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haghighat L, DeJong C, Teerlink J
Nat Cardiovasc Res
. 2024 Dec;
3(12):1389-1407.
PMID: 39632985
In the past decade, our understanding of heart failure pathophysiology has advanced significantly, resulting in the development of new medications such as angiotensin-neprilysin inhibitors, sodium-glucose cotransporter-2 inhibitors and oral soluble...
2.
Chen J, DeJong C, Agarwal M, Hairston A, Durstenfeld M, Mckay V, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e011121.
PMID: 39503613
Background: A polypill containing all 4 classes of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF) has been proposed to change the heart failure treatment paradigm. The...
3.
Hamo C, DeJong C, Hartshorne-Evans N, Lund L, Shah S, Solomon S, et al.
Nat Rev Dis Primers
. 2024 Aug;
10(1):55.
PMID: 39143132
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and has a prevalence that is expected to rise with the growing ageing population....
4.
Kazi D, DeJong C, Chen R, Wadhera R, Tseng C
J Am Coll Cardiol
. 2023 May;
81(21):2103-2111.
PMID: 37225364
Background: High out-of-pocket costs can impede access to guideline-directed cardiovascular drugs. The 2022 Inflation Reduction Act (IRA) will eliminate catastrophic coinsurance and cap annual out-of-pocket costs for Medicare Part D...
5.
Chiu N, Aggarwal R, Hernandez I, Wadhera R, DeJong C, Tseng C, et al.
Diabetes Care
. 2022 Aug;
45(11):e163-e164.
PMID: 36041194
No abstract available.
6.
Masuda C, Huynh T, Wong V, DeJong C, Tseng C
Pharmacy (Basel)
. 2022 Feb;
10(1).
PMID: 35202072
Pharmacists must be able to navigate prescription drug coverages to help providers and patients reduce out-of-pocket costs. Traditionally, curricula on drug insurance benefits rely on lectures and lack a practicum...
7.
Tseng C, Roh Y, DeJong C, Kanagusuku L, Soin K
Hawaii J Health Soc Welf
. 2021 Nov;
80(11):276-282.
PMID: 34765987
Reducing Coronavirus disease 2019 (COVID-19) transmission relies on people quarantining after exposure to COVID-19 or if they experience COVID-19 symptoms, and isolating from others if COVID-19 positive. Quarantine and isolation...
8.
Inoue K, Figueroa J, DeJong C, Tsugawa Y, Orav E, Shen C, et al.
Circ Cardiovasc Qual Outcomes
. 2021 May;
14(5):e007521.
PMID: 33966446
Background: Marketing payments from the pharmaceutical industry to physicians have come under scrutiny due to their potential to influence clinical decision-making. Two proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) were...
9.
Inoue K, DeJong C, Nangaku M
Endocr Pract
. 2021 May;
27(5):503-504.
PMID: 33934755
No abstract available.
10.
DeJong C, Spinelli M, Okochi H, Gandhi M
AIDS
. 2021 Mar;
35(9):1509-1511.
PMID: 33710026
No abstract available.